ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer
- 1 October 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 2 (10), 902-906
- https://doi.org/10.1097/jto.0b013e318155a637
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineAnnals Of Oncology, 2006
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancerCancer, 2006
- A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)Annals Of Oncology, 2006
- Expression profiling of primary non-small cell lung cancer for target identificationOncogene, 2002
- ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cellsInternational Journal of Cancer, 2000
- Overexpression of glutathione S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cellsFree Radical Research, 1999
- Analysis of Incision Sites Produced by Human Cell Extracts and Purified Proteins during Nucleotide Excision Repair of a 1,3-Intrastrand d(GpTpG)-Cisplatin AdductPublished by Elsevier BV ,1996
- Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patientsEuropean Journal Of Cancer, 1994
- Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.JCI Insight, 1994